Abstract
Cloning and immortalization of antibody-producing human B lymphocytes are required to establish monoclonal cell lines that secrete human immunoglobulin of predefined specificity. Such cultures may be obtained either (1) by transformation of normal B lymphocytes, e.g., by virus, or (2) by somatic cell hybridization of normal B lymphocytes with malignant cells, resulting in cell hybrids that have preserved the secretion of specific antibody of the B lymphocyte and the growth properties of the malignant cells. The former method has been used almost exclusively with Epstein—Barr virus (EBV) as the transforming agent, and some human monoclonal antibodies with interesting specificity have been obtained by this method (Steinitz et al., 1979; Zurawski et al., 1978; Irie et al.,1982; Watson et al., 1983; Rosen et al.,1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrams, P. G., Knost, J. A., Clarke, G., Wilburn, S., Oldham, R. K., and Foon, K. A., 1983, Determination of the optimal human cell lines for development of human hybridomas, J. Immunol. 131: 1201–1204.
Antel, J., Oger, J. J.-F., Iackevicius, S., Kuo, H. H., and Arnason, B. G. W., 1982, Modulation of T-lymphocyte differentiation antigens: Potential relevance for multiple sclerosis, Proc. Natl. Acad. Sci. USA 79: 3330–3334.
Brodin, T., Olsson, L., and Sjögren, H. 0., 1983, Cloning of human myeloma/hybridoma and lymphoma cell lines by enriched human monocytes as feeder layer, J. Immunol. Meth. 61: 1–7.
Bumol, T. F., and Reisfeld, R. A., 1982, Unique glycoprotein–proteoglycon complex defined by monoclonal antibody on human melanoma cells, Proc. Natl. Acad. Sci. USA 79: 1245–1249.
Cote, R. J., Morrissey, D. M., Houghton, A. N., Beattie, E. J., Oettgen, H. F., and Old, L. J., 1983, Generation of human monoclonal antibodies reactive with cellular antigens, Proc. Natl. Acad. Sci. USA 80: 2026–2030.
Croce, C. A., Linnenbach, A., Hall, W., Steplewski, Z., and Koprowski, H., 1980, Production of human hybridomas secreting antibody to measles virus, Nature 228: 486–488.
Doerfler, W., 1983, DNA methylation and gene activity, Annu. Rev. Biochem. 52: 93–124.
Feizi, T., 1984, Monoclonal antibodies reveal saccharine structures of glycoproteins and glycolipids as differentiation and tumor associated antigens, in: Genes and Antigens in Cancer Cells—The Monoclonal Antibody Approach ( G. Riethmuller, H. Koprowski, S. von Kleist, and K. Munk, eds.), Karger, Basel, pp. 51–63.
Frost, P., and Kerbel, R. S., 1983, On a possible epigenetic mechanism(s) of tumor cell heterogeneity, Cancer Metastasis Rev. 2: 375–378.
Frost, P., Liteplo, R. G., Donaghue, T. P., and Kerbel, R. S., 1984, Selection of strongly immunogenic “turn-” variants from tumors at high frequency using 5-azacytidine, J. Exp. Med. 159: 1491–1501.
Gallagher, R., Collins, S., Trufillo, J., McGredie, K., Ahearn, M., Tsai, S., Metzgar, R., Anlakh, G., Ting, R., Ruscetti, F., and Gallo, R. C., 1979, Characterization of the continuous differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia, Blood 54: 713–733.
Ginsburg, V., Fredman, P., and Magnani, J., 1984, Cancer associated carbohydrate antigens detected by monoclonal antibodies, in: Genes and Antigens in Cancer Cells—The Monoclonal Antibody Approach ( G. Riethmuller, H. Koprowski, S. von Kleist, and K. Munk, eds.), Karger, Basel, pp. 51–63.
Hakomori, S., and Kannagi, R., 1983, Glycosphingolipids as tumor-associated and differentiation markers, J. Natl. Cancer Inst. 71: 231–251.
Hansson, G. C., Karlsson, K.-A., Larson, G., McKibbin, J. M., Blaszcyzyk, M., Herlyn, M., Steplewsky, Z., and Koprowski, H., 1983, Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay,/ Biol. Chem. 258: 4091–4097.
Hawkes, R., Niday, E., and Gordon, J., 1982, A dot-immunobinding assay for monoclonal and other antibodies, Anal. Biochem. 1. 19: 142–147.
Hellström, K. E., Hellström, I., Brown, J. P., Larson, S. M., Nepom, G. T., and Carosquillo, J. A., 1984, Three human melanoma-associated antigens and their possible clinical applications, in: Genes and Antigens in Cancer Cells—The Monoclonal Antibody Approach ( G. Riethmuller, H. Koprowski, S. von Kleist, and K. Munk, eds.), Karger, Basel, pp. 121–131.
Heppner, G. H., 1984, Tumor heterogeneity, Cancer Res. 44: 2259–2265.
Holliday, R., and Pough, J. E., 1975, DNA modification mechanisms and gene activity during development, Science 187: 226–232.
Houghton, A. N., Brooks, H., Cote, R. J., Taormina, M. C., Oettgen, H. F., and Old, L. J., 1983, Detection of cell surface and intracellular antigens by human monoclonal antibodies: Hybrid cell lines derived from lymphocytes of patients with malignant melanoma, J. Exp. Med. 158: 53–65.
Irie, R. F., Sze, L. L., and Saxton, R. E., 1982, Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein–Barr virus-transformed human B-lymphoid cell lines, Proc. Natl. Acad. Sci. USA 79: 5666–5670.
Kaplan, H. S., Olsson, L., and Raubitschek, A., 1982, Monoclonal human antibodies: A recent development with wide-ranging clinical potential, in: Monoclonal Antibodies in Clinical Medicine ( A. J. McMichael and J. W. Fabre, eds.), Academic Press, London, pp. 17–35.
Kozbor, D., and Roder, J. C., 1983, The production of human monoclonal antibodies from human lymphocytes, Immunol. Today 4: 72–79.
Lane, D., and Koprowski, H., 1982, Molecular recognition and the future of monoclonal antibodies, Nature 296: 200–201.
Mitchell, M. S., and Oettgen, A. F. (eds.), 1983, Hybridomas in Cancer Diagnosis and Treatment, Raven Press, New York.
Nilsson, K., Bennich, H., Johansson, G. S. O., and Pontén, J., 1970, Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient, Clin. Exp. Immunol. 7: 477–489.
Old, L. J., Stockert, E., Bogse, E. A., and Kim, J. H., 1968, Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody—Study of the phenomenon in vitro, J. Exp. Med. 127: 523–529.
Olsson, L., 1983, Phenotypic diversity in leukemia cell populations, Cancer Metastasis Rev. 2: 153163.
Olsson, L., 1984, Human monoclonal antibodies: Methods of production and some aspects of their application in oncology, Med. Oncol. Tumor Pharmacother. 4: 235–246.
Olsson, L., Andreasen, R. B., Ost, Ake, Christensen, B., and Biberfeld, P., 1984, Antibody-producing human—human hybridomas II. Derivation and characterization of an antibody specific for human leukemia cells, J. Exp. Med. 159: 537–551.
Olsson, L., Due, C., Diamant, M., 1985, Treatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate. J. Cell. Biol. 100: 508–513.
Olsson, L., and Forchhammer, J., 1984, Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine and characterization of an antigen associated with metastatic activity, Proc. Natl. Acad. Sci. USA 81: 3389–3393.
Olsson, L., and Kaplan, H. S., 1980, Human—human hybridomas producing monoclonal antibodies of predefined antigenic specificity, Proc. Natl. Acad. Sci. USA 77: 5429–5431.
Olsson, L., and Kaplan, H. S., 1983, Human—human monoclonal antibody-producing hybridomas. Technical aspects, Meth. Enzymol. 92: 3–16.
Olsson, L., Kronstr¢m, H., Cambon-de-Mouzon, A., Honsik, C. J., Brodin, T., and Jacobsen, B., 1983, Antibody-producing human—human hybridomas. I. Technical aspects, J. Immunol. Meth. 61: 17–32.
Pettijohn, D., Henzl, M., and Price, C., 1984, Nuclear proteins which become part of the mitotic apparatus: A role in nuclear assembly?]. Cell Sci.,in press.
Razin, A., and Riggs, A. D., 1980, DNA methylation and gene regulation, Science 210:604–610. Reading, C. L., 1982, Theory and methods for immunization in culture and monoclonal antibody production, J. Immunol. Meth. 53: 261–291.
Riggs, A. D., and Jones, P. A., 1983, 5-Methylcytosine, gene regulation and cancer, Adv. Cancer Res. 40: 1–30.
Ritz, J., Pesando, J. M., Notis-McConarty, J., and Schlossman, S. F., 1980, Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro, J. Immunol. 125: 1506–1514.
Rosen, A., and Klein, G., 1983, UV-light-induced immunoglobulin heavy-chain class switch in a human lymphoblastoid cell line, Nature 306: 189–191.
Rosen, A., Persson, K., and Klein, G., 1983, Human monoclonal antibodies to a genus-specific chlamydial antigen produced by EBV-transformed B-cells, J. Immunol. 130: 2899–2902.
Schlom, J., Wunderlich, D., and Teramoto, Y. A., 1980, Generation of human monoclonal antibodies reactive with human mammary carcinoma cells, Proc. Natl. Acad. Sci. USA 77: 6841–6845.
Sikora, K., Alderson, J., Philips, J., and Watson, J. V., 1982, Human hybridomas from malignant gliomas, Lancet I:11–14.
Steinitz, M., Klein, G., Koskimies, S., and Kakela, 0., 1979, EB virus-induced cell lines producing specific antibody, Nature 269: 420–422.
Van Ness, J., Laemmli, U. K., and Pettijohn, D. E., 1984, Immunization in vitro and production of monoclonal antibodies specific to insoluble and weakly immunogenic proteins, Proc. Natl. Acad. Sci. USA 81: 7897–7901.
Watson, D. B., Burns, G. F., and Makay, I. R., 1983, In vitro growth of B-lymphocytes infiltrating human melanoma tissue by transformation with EBV: Evidence for secretion of anti-melanoma antibodies by some transformed cells, J. Immunol. 130: 2442–2447.
Zurawski, V. R., Haber, E., and Black, P. M., 1978, Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines, Science 119: 1439–1441.
Acton, R. T., Barstad, P. A., and Zuerner, R. K., 1979, Propagation and scaling-up of suspension culture, Meth. Enzymol. LVIII: 211–221.
Chang, T. H., Steplewski, Z., and Koprowski, H., 1980, Production of monoclonal antibodies in serum-free medium, J. Immunol. Meth. 39: 369–375.
Erhlich, K. C., Stewart E., and Klein, E., 1978, Artificial capillary perfusion cell culture: Metabolic studies, In Vitro 14: 443–450.
Fazekas de St. Groth, S., 1983, Automated production of monoclonal antibodies in a cytostat, J. Immunol. Meth. 57: 121–136.
Feder, J., and Tolbert, W. R., 1983, Large scale cultivation of mammalian cells, Sci. Am. 248: 3643.
Finter, N. B., and Fantes, K. H., 1980, The purity and safety of interferons prepared for clinical use: The case for lymphoblastoid interferon, In: Interferon II, I. Gessor, ed., Academic Press, New York, pp. 65–80.
Girard, H. C., Sutcu, M., Erden, H., and Gurhan, I., 1980, Monolayer cultures of animal cells with the cyrogen equipped with tubes, Biotechnol. Bioeng. 22: 477–493.
Glacken, M. W., Fleischaker, R. J., and Sinskey, A. J., 1983, Mammalian cell culture: Engineering principles and scale-up, Trends Biotechnol. 1: 102–108.
Himmelfarb, P., Thayer, P. S., and Martin, H. E., 1969, Spin filter culture: The propagation of mammalian cells in suspension, Science 164: 555–557.
Hopkinson, J., 1982, Hollow Fiber Cell Culture: A Sleeping Giant Awakening, Amicon Literature, Amicon Corp., Lexington, Massachusetts.
Iscove, N. N., and Melchers, 1978, Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes, J. Exp. Med. 147: 923933.
Jarvis, A. P., and Grdina, T. A., 1983, Production of biologicals from microencapsulated living cells, Bio Techniques 1: 24–27.
Kawamoto, T., Sato, J. D., Lo, A., McClure, D. B., and Sato, G. H., 1983, Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas, Anal. Biochem. 130: 445–453.
Knazek, R. A., Gullino, P. M., Kohler, P. O., and Dedrick, R. L., 1972, Cell culture on artificial capillaries: An approach to tissue culture in vitro, Science 178: 65–67.
Kruse, P. F., Jr., and Patterson, M. K. Jr., (eds.), Tissue Culture, Methods and Applications,Volume XXVII, Academic Press, New York, pp. 283–363.
Lewis, C., Tolbert, W. R., and Feder, J., 1984, Large scale perfusion culture system for production of monoclonal antibodies, presented at Hybridoma Conference, San Diego, California.
Lim, F., and Sun, A., 1980, Microencapsulated islets of bioartificial endocrine pancreas, Science 210: 908–910.
Littlefield, S. G., Gilligan, K. J., and Jarvis, A. P., 1983, Growth and monoclonal antibody production from rat x mouse hybridomas: A comparison of microcapsule culture with conventional suspension culture, presented at Hybridoma Conference, San Diego, California.
Litwin, J., 1973, Titanium disks, In: Tissue Culture Methods and Applications, P. F. Kruse, Jr., and M. K. Patterson, Jr., eds., Academic Press, New York, Chapter 5.
Lydersen, B. K., Pugh, G. G., Duncan, E. C., Overman, K. T., Johnson, D. M., and Sharma, B. P., 1983, Novel ceramic material for large scale cell culture, presented at Tissue Culture Association, 34th Annual Meeting, Orlando, Florida, June 12–16.
Lynn, J. D., and Acton, R. T., 1975, Design of a large scale mammalian cell suspension culture facility, Biotechnol. Bioeng. XVII: 659–673.
McHugh, Y. E., Walthall, B. J., and Steimer, K. S., 1983, Serum-free growth of murine and human lymphoid and hybridoma cell lines, Biotechniques 1: 72–77.
McLimans, W. F., 1979, Mass culture of mammalian cells, Meth. Enzymol. LVIII:194–211.
Murakami, H., Masui, H., Sato, G. H., Sueoka, N., Chow, T. P., and Kano-Sueoka, T., 1982, Growth of hybridoma cells in serum-free medium: Ethanolamine is an essential component, Proc. Natl. Acad. Sci. USA 79: 1158–1162.
Patterson, N. K., Jr., 1976, Perfusion and mass culture systems, Tiss. Culture Assoc. Manual 4: 243–249.
Pharmacia, 1981, Microcarrier Cell Culture: Principles and Methods, Pharmacia Fine Chemicals AB, Uppsala, Sweden.
Pollard, R., and Khosrovi, B., 1978, Reactor design for fermentation of fragile tissue cells, Process Biochem. 78: 31–37.
Quarles, J. M., Morris, N. G., and Leibovitz, A., 1980, Carcinoembryonic antigen production by human colorectal adenocarcinoma cells in matrix-perfusion culture, In Vitro 16: 113–118.
Reuveny, S., Mizrahi, A., Kotler, M., and Freeman, A., 1983, Factors affecting cell attachment, spreading and growth on derivatized microcarriers. I. Establishment of working system and effect of the type of the amino-charged groups, Biotechnol. Bioeng. 25: 469–480
Reuveny, S., Mizrahi, A., Kotler, M., and Freeman, A., 1983, Introduction of hydrophobic elements, Biotechnol. Bioeng. 25: 2969–2981.
Sato, G., Pardee, A. B., and Sirbasku, D. A. (eds.), 1982, Growth of Cells in Hormonally Defined Media, Parts A, B, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
Thayer, P. S., 1973, Spin filter device for suspension cultures, In: Tissue Culture, Methods and Applications, P. F. Kruse, Jr. and M. K. Patterson, Jr., eds., Academic Press, New York, pp. 345–351.
Thilly, W. G., Barngrover, D., and Thomas, J. N., 1982, Microcarriers and the problem of high cell density culture, In: From Gene to Protein: Translation into Biotechnology, F. Ahmad, J. Schultz, E. E. Smith, and W. I. Whelan, eds., Academic Press, New York, pp. 75–103.
Tolbert, W. R., and Feder, J., 1983, Large scale cell culture technology, Annu. Rep. Fermentation Processes 6: 35–74.
Tolbert, W. R., Feder, J., and Kimes, R. C., 1981, Large scale rotating filter perfusion systems for high density growth of mammalian suspension cultures, In Vitro 17: 885–890.
Uittenbogaart, C. H., Cantor, Y., and Fahey, J. L., 1983. Growth of human malignant lymphoid cell lines in serum-free medium, In Vitro 19: 67–72.
Van Wezel, A. L., and Van der Velden-de Groot, C. A. M., 1978, Large scale cultivation of animal cells in microcarrier culture, Process Biochem. 78: 6–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Olsson, L., Brams, P. (1985). Human—Human Hybridoma Technology. In: Engleman, E.G., Foung, S.K.H., Larrick, J.W., Raubitschek, A.A. (eds) Human Hybridomas and Monoclonal Antibodies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4949-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4949-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4951-8
Online ISBN: 978-1-4684-4949-5
eBook Packages: Springer Book Archive